These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 35925809)

  • 21. 'Treat my whole person, not just my condition': qualitative explorations of hepatitis C care delivery preferences among people who inject drugs.
    Tsui JI; Barry MP; Austin EJ; Sweek EW; Tung E; Hansen RN; Ninburg M; Scott JD; Glick SN; Williams EC
    Addict Sci Clin Pract; 2021 Aug; 16(1):52. PubMed ID: 34384494
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hepatitis C Virus Treatment Delivered via Telemedicine to Persons With Opioid Use Disorder.
    Talal AH; Dinani A; Brown LS
    JAMA Intern Med; 2022 Sep; 182(9):1011. PubMed ID: 35816336
    [No Abstract]   [Full Text] [Related]  

  • 23. A multi-methods and longitudinal study of patients' perceptions in injectable opioid agonist treatment: Implications for advancing patient-centered methodologies in substance use research.
    Marchand K; Palis H; Guh D; Lock K; MacDonald S; Brissette S; Marsh DC; Harrison S; Schechter MT; Oviedo-Joekes E
    J Subst Abuse Treat; 2022 Jan; 132():108512. PubMed ID: 34098207
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Advancing virtual primary care for people with opioid use disorder (VPC OUD): a mixed-methods study protocol.
    Hedden L; McCracken RK; Spencer S; Narayan S; Gooderham E; Bach P; Boyd J; Chakanyuka C; Hayashi K; Klimas J; Law M; McGrail K; Nosyk B; Peterson S; Sutherland C; Ti L; Yung S; Cameron F; Fernandez R; Giesler A; Strydom N
    BMJ Open; 2022 Sep; 12(9):e067608. PubMed ID: 36167365
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Integrated treatment of hepatitis C virus infection among people who inject drugs: study protocol for a randomised controlled trial (INTRO-HCV).
    Fadnes LT; Aas CF; Vold JH; Ohldieck C; Leiva RA; Chalabianloo F; Skurtveit S; Lygren OJ; Dalgård O; Vickerman P; Midgard H; Løberg EM; Johansson KA;
    BMC Infect Dis; 2019 Nov; 19(1):943. PubMed ID: 31703669
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A pilot study of a mixed-method approach to design an ED-based peer mHealth referral tool for HIV/HCV and opioid overdose prevention services.
    Knaub RJ; Evans J; Yang C; Roura R; McGinn T; Verschoore B; Ricketts EP; Rothman RE; Latkin CA; Hsieh YH
    Drug Alcohol Depend; 2022 Sep; 238():109585. PubMed ID: 35926299
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effect of bundling medication-assisted treatment for opioid addiction with mHealth: study protocol for a randomized clinical trial.
    Gustafson DH; Landucci G; McTavish F; Kornfield R; Johnson RA; Mares ML; Westergaard RP; Quanbeck A; Alagoz E; Pe-Romashko K; Thomas C; Shah D
    Trials; 2016 Dec; 17(1):592. PubMed ID: 27955689
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Telemedicine as an environmental ally - The social, financial, and environmental impact of virtual care in the otolaryngology clinic.
    Tselapedi-Sekeitto B; Rocha T; Sowerby LJ; Rotenberg B; Biadsee A
    Am J Otolaryngol; 2023; 44(2):103791. PubMed ID: 36706717
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Disparities in Patient-Centered Communication via Telemedicine.
    Paige SR; Bunnell BE; Bylund CL
    Telemed J E Health; 2022 Feb; 28(2):212-218. PubMed ID: 33913764
    [No Abstract]   [Full Text] [Related]  

  • 30. Association Between Prescription Opioid Therapy for Noncancer Pain and Hepatitis C Virus Seroconversion.
    Wilton J; Wong S; Purssell R; Abdia Y; Chong M; Karim ME; MacInnes A; Bartlett SR; Balshaw RF; Gomes T; Yu A; Alvarez M; Dart RC; Krajden M; Buxton JA; Janjua NZ
    JAMA Netw Open; 2022 Jan; 5(1):e2143050. PubMed ID: 35019983
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Patient and physician satisfaction with telemedicine in pediatric otolaryngology.
    Pakanati V; Raol N; Ching Siong T; Govil N
    Int J Pediatr Otorhinolaryngol; 2022 May; 156():111097. PubMed ID: 35259634
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Characteristics and current clinical practices of opioid treatment programs in the United States.
    Jones CM; Byrd DJ; Clarke TJ; Campbell TB; Ohuoha C; McCance-Katz EF
    Drug Alcohol Depend; 2019 Dec; 205():107616. PubMed ID: 31678836
    [TBL] [Abstract][Full Text] [Related]  

  • 33. How to build trustworthy hepatitis C services in an opioid treatment clinic? A qualitative study of clients and health workers in a co-located setting.
    Treloar C; Rance J;
    Int J Drug Policy; 2014 Sep; 25(5):865-70. PubMed ID: 24559604
    [TBL] [Abstract][Full Text] [Related]  

  • 34. "Take Charge, Get Cured": Pilot testing a targeted mHealth treatment decision support tool for methadone patients with hepatitis C virus for acceptability and promise of efficacy.
    Jessop AB; Bass SB; Brajuha J; Alhajji M; Burke M; Gashat MT; Wellington C; Ventriglia N; Coleman J; D'Avanzo P
    J Subst Abuse Treat; 2020 Feb; 109():23-33. PubMed ID: 31856947
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A qualitative study of perceived barriers to hepatitis C care among people who did not attend appointments in the non-urban US South.
    Sherbuk JE; Tabackman A; McManus KA; Kemp Knick T; Schexnayder J; Flickinger TE; Dillingham R
    Harm Reduct J; 2020 Sep; 17(1):64. PubMed ID: 32948189
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Physician satisfaction with telemedicine and in-person visits in otolaryngology.
    Choi JS; Lin M; Park S; Abdur-Rahman F; Kim JH; Voelker CCJ
    Am J Otolaryngol; 2022; 43(5):103596. PubMed ID: 35969912
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A qualitative study of patient experiences with telemedicine opioid use disorder treatment during COVID-19.
    Lockard R; Priest KC; Gregg J; Buchheit BM
    Subst Abus; 2022; 43(1):1150-1157. PubMed ID: 35499402
    [No Abstract]   [Full Text] [Related]  

  • 38. Satisfaction of patients with health care services in tertiary care facilities of Riyadh, Saudi Arabia: A cross-sectional approach.
    Aljarallah NA; Almuqbil M; Alshehri S; Khormi AMS; AlReshaidan RM; Alomran FH; Fawzan Alomar N; Alshahrani FF; Alshammari MS; Alsanie WF; Alhomrani M; Alamri AS; Asdaq SMB
    Front Public Health; 2022; 10():1077147. PubMed ID: 36711344
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Viral Hepatitis and Human Immunodeficiency Virus Testing and Linkage to Care for Individuals Enrolled in an Opioid Treatment Program.
    Rowan SE; Kamis KF; Beum R; Bryan K; Gawenus L; Colon Sanchez D; Hurley H
    J Infect Dis; 2020 Sep; 222(Suppl 5):S384-S391. PubMed ID: 32877565
    [TBL] [Abstract][Full Text] [Related]  

  • 40. High HCV cure rates among people who inject drugs and have suboptimal adherence: A patient-centered approach to HCV models of care.
    Norton BL; Akiyama MJ; Arnsten JH; Agyemang L; Heo M; Litwin AH
    Int J Drug Policy; 2021 Jul; 93():103135. PubMed ID: 33667826
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.